Table 1 Correlation between miR-199a-5p expression and clinicopathological characteristics of bladder cancer patients
From: miR-199a-5p suppresses human bladder cancer cell metastasis by targeting CCR7
Characteristics | Total | Expression of miR-199a-5p | P value | |
|---|---|---|---|---|
High (n = 13) | Low (n = 27) | |||
Age | 0.758 | |||
≤ 60 | 16 | 6(37.5 %) | 10(62.5 %) | |
> 60 | 24 | 7(29.2 %) | 17(70.8 %) | |
Gender | 0.316 | |||
Male | 25 | 10(40 %) | 15(60 %) | |
Female | 15 | 3(20 %) | 12(70 %) | |
TNM stage | <0.001** | |||
0/I | 5 | 3(60 %) | 2(40 %) | |
II/III/IV | 35 | 10(28.6 %) | 25(71.4 %) | |
Tumor size | 0.501 | |||
< 3 cm | 16 | 4(40 %) | 12(60 %) | |
≥ 3 cm | 24 | 9(37.5 %) | 15(62.5 %) | |
Histological grade | 0.003** | |||
PUNLMP/Low-grade | 21 | 11(52.3 %) | 10(47.7 %) | |
High-grade | 19 | 2(10.5 %) | 17(89.5 %) | |
Tumor invasion depth (T) | <0.001** | |||
Tis, Ta, T1 | 19 | 12(60 %) | 7(40 %) | |
T2, T3 or above | 21 | 1(10 %) | 20(90 %) | |
Lymph node metastasis (N) | <0.001** | |||
N0 | 12 | 5(41.7 %) | 7(58.3 %) | |
N1 or above | 28 | 8(28.6 %) | 20(71.4 %) | |